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Background: Several studies have found that DDR2 is up-regulated in many tumor types and facilitates tumor
progression. However, the role of DDR2 in hepatocellular carcinoma (HCC) progression and its downstream
signaling pathways remain unclear.
Methods: DDR2 expression was assessed in several cell lines and 112 pairs of HCC and matched adjacent
noncancerous liver tissues. Clinical significance of DDR2 in HCC was analyzed. Phosphorylated DDR2 (p-DDR2)
expression was detected by immunoblotting to evaluate its correlation with DDR2. The effect of DDR2 on HCC
cell migration and invasion were examined. Cycloheximide chase experiments were performed to detect the
half-life of SNAIL1. Moreover, DDR2 expression was detected by immunohistochemistry to evaluate its correlation
with SNAIL1. The regulatory effect of DDR2 on ERK signaling, SNAIL1, EMT, MT1-MMP and MMP2 was confirmed
by immunoblotting. The effect of type I collagen on DDR2/ERK2/SNAIL1 signaling was assessed.
Results: DDR2 was more highly expressed in HCC than in non-HCC tissues. DDR2 overexpression was correlated
with clinicopathological features of poor prognosis. Clinical analysis revealed that DDR2 is an independent
prognostic marker for predicting overall survival and disease free survival of HCC patients. Overexpression of
DDR2 is associated with p-DDR2 amplification. In vitro studies showed that DDR2 facilitates HCC cell invasion,
migration and EMT via activating ERK2 and stabilizing SNAIL1. DDR2 can up-regulate MT1-MMP and MMP2
expression through ERK2/SNAIL1 signaling in HCC. Additionally, collagen I can induce DDR2/ERK2/SNAIL1
signaling activation in HCC cells.
Conclusions: Our findings suggest that DDR2 plays an important role in promoting HCC cell invasion and
migration, and may serve as a novel therapeutic target in HCC.
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Hepatocellular carcinoma (HCC) is one of the most
prevalent malignant tumors worldwide and is the second
leading cause of cancer-related death in China [1–3]. In
recent years, the incidence of HCC is increasing in many
parts of the world including the United States, partly due
to the rise in hepatitis C virus infection [4–6]. Hepatic* Correspondence: lihp1979@163.com; tgs918@163.com
†Equal contributors
4Department of Medical Imaging, The First Affiliated Hospital of Sun Yat-sen
University, Guangzhou 510080, China
Full list of author information is available at the end of the article
© 2015 Xie et al. Open Access This article is d
International License (http://creativecommons
reproduction in any medium, provided you g
the Creative Commons license, and indicate if
(http://creativecommons.org/publicdomain/zeresection offers the chance of a cure for patients with
HCC, but the prognosis remains very poor [7, 8]. Hence,
understanding the molecular mechanisms involved in
hepatocarcinogenesis and exploring prognostic markers
and therapeutic targets of HCC is urgently needed.
The discoidin domain receptors (DDRs), consisting of
DDR1 and DDR2, are distinctive receptor tyrosine ki-
nases (RTKs) and signal in response to collagens instead
of soluble peptide growth factors [9–11]. Multiple stud-
ies have suggested that DDR2 can regulate cell adhesion,
migration and matrix remodeling [12, 13]. DDR2 have
also been shown to exhibit aberrant expression patternsistributed under the terms of the Creative Commons Attribution 4.0
.org/licenses/by/4.0/), which permits unrestricted use, distribution, and
ive appropriate credit to the original author(s) and the source, provide a link to
changes were made. The Creative Commons Public Domain Dedication waiver
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Table 1 Correlations between DDR2 expression and
clinicopathologic features in HCC
Characteristics n DDR2 expression P value
High Low
Gender
Female 25 15 10
Male 87 41 46 0.364
Age (year)
≤ 45 29 10 19
> 45 83 46 37 0.083
HBsAg statusa
Negative 22 7 15
Positive 90 49 41 0.095
Cirrhosis
No 37 15 22
Yes 75 41 34 0.228
AFP (μg/l)b
≤ 400 55 23 32
> 400 57 33 24 0.130
Tumor size
≤ 5 cm 37 14 23
> 5 cm 75 42 33 0.107
Tumor number
Single 86 37 49
Multiple 26 19 7 0.013*
Tumor capsule
Complete 20 7 13
Incomplete 92 49 43 0.217
Vascular invasion
No 86 36 50
Yes 26 20 6 0.003*
Edmondson grade
I/II 64 24 40
III/IV 48 32 16 0.004*
TNM stage
I/II 67 25 42
III/IV 45 31 14 0.002*
aHbsAg hepatitis B surface antigen, bAFP a-fetoprotein, *P < 0.05
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prostate cancer [14–16]. Furthermore, it was found that
the abnormal expression of DDR2 implicated in cancer
progression and a poor prognosis [17, 18]. However,
the role of DDR2 in HCC and the molecular mecha-
nisms by which DDR2 exerts its biological function are
still unclear.
SNAIL1, a member of transcription factors, is critical for
inducing and sustaining cancer epithelial–mesenchymal
transition (EMT) [19, 20]. SNAIL1-induced EMT has been
demonstrated essential for promoting tumor cell migration
and invasion in multiple tumor types [21, 22]. Recently,
Zhang et al. have found that SNAIL1 is regulated by the
DDR2/ERK2 signaling pathway in breast cancer [23]. In the
previous studies, ERK signaling pathway has been consid-
ered to promote the progression of HCC [24, 25]. It is also
known that SNAIL1 plays an essential role in regulating
HCC EMT [26, 27]. However, whether DDR2 is implicated
in regulating the ERK signaling and SNAIL1 in HCC has
not been clarified.
As representative epithelial-specific and mesenchymal-
specific biomarkers, E-cadherin and Vimentin are crucial
factors in the invasion, migration and EMT of HCC [21].
Down-regulation of E-cadherin and up-regulation of
Vimentin are used as biomarkers indicating an epithelial
cell has undergone EMT in HCC [21]. Multiple studies
have revealed that EMT associated with patients poor
prognosis is an important step in the invasion and mi-
gration of HCC [21, 26]. Importantly, SNAIL1-induced
E-cadherin down-regulation and Vimentin up-regulation
have been demonstrated essential for triggering the EMT
of HCC [27]. However, whether DDR2 is implicated in
regulating the expression of E-cadherin and Vimentin in
HCC are still unknown.
In this study, we found that DDR2 was more highly
expressed in HCC tissues than that in non-tumor tissues,
and DDR2 overexpression was correlated with poor clini-
copathological features and outcome of HCC patients.
Our study demonstrated that DDR2 has an oncogenic role
in HCC tumorigenesis by facilitating cancer cell invasion,
migration and epithelial–mesenchymal transition via acti-
vating ERK signaling and stabilizing SNAIL1. Additionally,
DDR2 can up-regulate membrane type-1 matrix metallo-
proteinase (MT1-MMP) and MMP2 expression through
ERK2/SNAIL1 signaling in HCC. Our study identified that
DDR2 is a novel regulator of EMT through stabilizing
SNAIL1, indicating its potential therapeutic value for
reducing HCC invasion and metastasis.
Materials and methods
Tissue samples
A total of 112 pairs of HCC and corresponding adjacent
non-tumorous liver tissues (>2.0 cm from the resec-
tion margin) were obtained from patients undergoinghepatectomy between February 2007 and December
2009 at the Department of Hepatobiliary Surgery, the
First Affiliated Hospital of Gannan Medical University.
The patient characteristics are shown in Table 1. All
patients provided written informed consent before hep-
atectomy, and our study were approved by the Ethics
Committee of the First Affiliated Hospital of Gannan
Medical University according to the 1975 Declaration
of Helsinki.
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The immortalized normal human liver cell line L02 and
five HCC cell lines including SMMC-7721, Huh-7, HepG2,
Hep3B and MHCC-97H were obtained from from the Type
Culture Collection of the Chinese Academy of Sciences
(Shanghai, China). All cell lines were cultured in Dulbecco’s
modified Eagle medium (DMEM, Gibco, Grand Island, NY,
USA) containing 10 % fetal bovine serum (FBS, Gibco).Quantitative reverse transcription-polymerase chain
reaction (qRT-PCR)
Total RNA was extracted using TRIzol reagent (Invitrogen,
USA). qRT-PCR was done in an ABI 7500 system using the
SYBR® Premix Ex Taq™ II (Tli RNaseH Plus) (TakaRa,
Japan). DDR2 primers: forward 5’-CTCCCAGAATTTGC
TCCAG-3’; reverse 5’-GCCACATCTTTTCCTGAGA-3-3’.
SNAIL1 primers: forward 5’- GCT CCACAAGCACCAAG
AGT-3’; reverse 5’- ATTCCATGGCAGTGAGAAGG-3’.
β-actin primers: forward 5’-GGGAA ATCGTGCGTGAC
AT-3’; reverse 5’-C TGGA AGGTGGACAGCGAG-3’.Western immunoblotting
The following primary antibodies were used in the western
immunoblotting assays: SNAIL1 (ab180714, Abcam,
Cambridge, UK), Vimentin (ab137321, Abcam, Cambridge,
UK), E-cadherin (ab15148, Abcam, Cambridge, UK), MT1-
MMP (ab53712, Abcam, Cambridge, UK), DDR2 (sc-8989,
Santa Cruz, CA, USA), p-DDR2 (MAB25382, R&D systems
Inc, USA), ERK1/2 (sc-292838, Santa Cruz, CA, USA),
p-ERK1/2 (sc-101760, Santa Cruz, CA, USA), MMP2
(sc-10736, Santa Cruz, CA, USA) and β-actin polyclonal
antibody (sc-130656, Santa Cruz, CA, USA). Immunoblot-
ting assays were performed as reported previously [3].Immunohistochemical staining
Immunohistochemical assay was performed on parafor-
maldehyde-fixed paraffin sections as previous reported
[28]. The DDR2 (sc-8989, Santa Cruz, CA, USA) and
SNAIL1 (ab180714, Abcam, Cambridge, UK) primary
antibodies were used at a 1:100 dilution in the immuno-
histochemistry assays. The immunostaining intensity and
average percentage of positive cells were evaluated as
previous reported [28]. Immunostaining intensity was
evaluated as four grades: 0, negative; 1, weak; 2, moderate;
3, strong. And the percentage of positive cells was catego-
rized as the following grades: 0, 0 %; 1, 1 to 10 %; 2, 11 to
50 %; 3, 51 to 80 %; and 4 > 80 %. The immunostaining
intensity and average percentage of positive cells were
evaluated for ten independent high magnification fields.
By multiplying the staining intensity and the percentage
of positive cells, the final weighed expression score was
obtained (0–12).Expressing plasmids and RNAi transfection
The DDR2 expressing plasmid and its empty plasmid
pCMV6-XL6 were both obtained from Origene Tech-
nologies Inc. (Rockville, USA). DDR2 expressing plasmid
or empty plasmid pCMV6-XL6 was transfected into
Hep3B cells using TurboFectin Transfection Reagent
purchased from Origene Technologies Inc. (Rockville,
USA). The DDR2 shRNA and scrambled shRNA vector
pRS were also purchased from Origene Technologies
Inc. (Rockville, USA). DDR2 unique 29mer shRNA con-
structs in pRS Vector or scrambled shRNA vector pRS
was transfected into MHCC-97H cells using TurboFectin
Transfection Reagent purchased from Origene Technolo-
gies Inc. (Rockville, USA). The specific siRNA sequences
against ERK2 (sc-35335), against SNAIL1 (sc-38398) and
the scramble siRNAs (sc-37007) were obtained from Santa
Cruz Biotechnology (Santa Cruz, USA).Cycloheximide (CHX) chase experiments
To assess SNAIL1 protein stability, HCC cells were treated
with 50 mg/ml cycloheximide (final concentration, Sigma)
following expressing plasmids or RNAi transfection for
72 h. At the given time points, HCC cells were harvested,
flash-frozen, and analyzed by Western blotting as described
above. SNAIL1 protein degradation rates were quantified
by densitometry using time point zero as 100 %.Co-Immunoprecipitation assay
Total protein lysate was obtained in immunoprecipitation
buffer. The lysate was precleared with protein A/G-agarose
beads. Total protein in supernatants was qualified by BCA
method. Then, total protein was diluted into 1 μg/μL with
PBS and mixed with primary antibodies against DDR2,
SNAIL1, ERK2 or IgG. The mixtures were shaken on
rotating shaker for overnight at 4 °C. The supernatant
was obtained and used in the immunoblotting assay.Transwell migration and invasion assays
Transwell migration assays were performed in 12 well
plates with 8-μm BioCoat control inserts (Bedford, MA).
HCC cells that were suspended in serum-free medium
were added into the upper chamber and medium with
10 % FBS was added into the lower chamber. The cells
on the inner layer were softly removed and the adherent
tumor cells on undersurface of the insert were stained with
crystal violet. Transwell invasion assays were performed in
BioCoat Matrigel invasion chamber containing an 8 μm
pore-size PET membrane with a uniform layer of BD
Matrigel basement membrane matrix (Becton Dickinson
Labware). The following protocols were the same as cell
migration assays.
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Data were showed as the Mean ± SEM. Statistical signifi-
cance was established, with the SPSS 16.0 statistical soft-
ware package (SPSS Inc., Chicago, IL), using a two-tailed
Student’s t test, a Kaplan–Meier plot, a log-rank test, a
Spearman correlation coefficient analysis, a Chi-square
test or Fisher’s exact test. Independent prognostic factors
were assessed by the Cox proportional hazards stepwise
regression model. P values were 2-sided and a P value of
less than 0.05 was considered statistical significance.
Results
Up-regulation of DDR2 is a frequent event in HCC lines
We first analyzed DDR2 expression in an immortalized
non-tumourigenic hepatocyte cell line L02 and a panel
of HCC cell lines (SMMC-7721, Huh-7, HepG2, Hep3B
and MHCC-97H) using qRT-PCR and Western blotting.
We found that DDR2 expression was evidently up-
regulated in all HCC cell lines as compared with that in
a non-tumourigenic hepatocyte cell line L02 (P < 0.01,
respectively, Fig. 1a-b). Furthermore, DDR2 expression
in the highly invasive HCC cell line (MHCC-97H) were
evidently higher than those in the low invasive HCC
cell lines including SMMC-7721, Huh-7, HepG2, Hep3B
(P < 0.01, respectively, Fig. 1a-b). The characteristics ofFig. 1 The expression of DDR2 in cell lines and HCC tissues. a DDR2 mRNA
five hepatoma cell lines (MHCC-97H, HepG2, Huh-7, Hep3B and SMMC-
the immortalized normal human liver cell line L-02 and five hepatoma
immunoblotting (n = 3, P < 0.01). c DDR2 mRNA expression in HCC tissu
qRT-PCR (n = 112, P < 0.01). d The protein expression of DDR2 and phos
adjacent no tumorous tissues (N) using immunoblotting (n = 112, P < 0.each cell line are shown in Table 2. Our data indicates that
elevated DDR2 expression confers increased invasive po-
tential of HCC cells. In our study, MHCC-97H expressed
the highest expression level of DDR2 in HCC cell lines
and the Hep3B expressed the lowest expression level of
DDR2 among the five HCC cell lines. Thereby, Hep3B cell
line was selected for DDR2 overexpression experiment
here, while MHCC-97H cell line were used in DDDR2
knockdown experiment.
Clinical significance of DDR2 expression in HCC tissues
To analyze the clinical significance of DDR2 in HCC, we
detected the DDR2 expression in 112 pairs of HCC and
matched tumor-adjacent samples using qRT-PCR and
Western blotting, and found that DDR2 expression was
prominently higher in the HCC samples than that in the
noncancerous samples (P < 0.01, respectively, Fig. 1c-d).
In our study, we also detected the phosphorylated DDR2
(p-DDR2) expression in HCC, which was previously
shown to be associated with DDR2 activation. We found
that p-DDR2 expression level was evidently higher in
the HCC samples than that in the noncancerous samples
(P < 0.01, Fig. 1d). To further identify the clinical role of
DDR2 in HCC, we detected the correlations of the DDR2
protein expression with clinicopathological characteristics,expression in the immortalized normal human liver cell line L-02 and
7721) using qRT-PCR (n = 3, *P < 0.01). b DDR2 protein expression in
cell lines (MHCC-97H, HepG2, Huh-7, Hep3B and SMMC-7721) using
es (T) and corresponding adjacent no tumorous tissues (N) using
phorylated DDR2 (p-DDR2) in HCC tissues (T) and corresponding
01, respectively)
Table 2 Characteristics of the cell lines used in this study
Cell line Type Characteristics
HBsAga P53 AFPb Invasion & migration
L02 Liver cell line Negative Wild type p53 Negative No
Hep3B Hepatoma cell line Positive P53 deletion Positive Low
HepG2 Hepatoma cell line Negative Wild type p53 Positive Low
Huh-7 Hepatoma cell line Negative P53 mutation Positive Low
SMMC-7721 Hepatoma cell line Negative P53 mutation Positive Low
MHCC-97H Hepatoma cell line Positive P53 mutation Positive High
aHbsAg hepatitis B surface antigen, bAFP a-fetoprotein
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size, liver cirrhosis, capsule formation, Edmondson-Steiner
grade, tumor number, vascular invasion and TNM stage.
In this study, the median DDR2 protein expression level
was used as the cutoff point to divide into low-expressing
and high expressing groups. Strikingly, DDR2 expression
was evidently correlated with tumor number, vascular
invasion, Edmondson-Steiner grade and TNM stage
(Table 1). However, no relationship was found between
the DDR2 expression and other clinicopathological char-
acteristics including gender, age, HBsAg status, AFP level,
tumor size, liver cirrhosis, capsule formation (Table 1).
DDR2 expression is an independent prognostic factor for
HCC
In this study, the median DDR2 protein expression was
used as the cutoff point to divide into high-expressingFig. 2 Prognostic value of DDR2 protein expression in HCC and its correlation
DDR2 protein expression (log-rank, P < 0.01). b Disease-free survival for D
of DDR2 and p-DDR2 in Hep3B cells with DDR2 expressing plasmid trans
DDR2 and p-DDR2 in MHCC-97H cells with DDR2-shRNA transfection or cand low-expressing groups for HCC patients’ survival.
HCC patients in the high DDR2-expressing group had
obviously reduced overall survival and disease-free
survival. The 5-year overall survival rate of the high
DDR2-expressing group was significantly lower than
that of the low DDR2-expressing group (P < 0.01) (Fig. 2a).
The 5-year disease-free survival rate of the high DDR2-
expressing group was obviously lower than that of the low
DDR2-expressing group (P < 0.01) (Fig. 2b). In our study,
we also performed Univariate analysis and Cox propor-
tional hazards regression analysis. The univariate analysis
revealed that DDR2 level, HBsAg status, tumor number,
vascular invasion, Edmondson-Steiner grade and TNM
stage were the prognosis factors for HCC patients (Table 3).
In a multivariate analysis model, DDR2 expression level
was obviously associated with overall survival (HR 2.169;
95 % CI, 1.198–3.927; P < 0.05) and disease-free survivalwith phosphorylated DDR2 (p-DDR2) in HCC cells. a Overall survival for
DR2 protein expression (log-rank, P < 0.01). c Immunoblotting analysis
fection or control plasmid transfection. d Immunoblotting analysis of
ontrol-shRNA transfection
Table 3 Univariate prognostic analysis of overall survival and disease-free survival in HCC patients
Variable n Overall survival rate (%) Disease-free survival rate (%)
3y 5y P value 3y 5y P value
Gender
Female 25 87.7 66.8 56.0 44.0
Male 87 60.9 46.4 0.100 47.1 31.8 0.234
Age (year)
≤ 45 29 82.4 57.3 62.1 37.9
> 45 83 61.4 40.8 0.417 44.6 34.7 0.639
HBsAg statusa
Negative 22 90.5 85.4 72.7 59.1
Positive 90 61.1 41.4 0.008* 43.3 29.6 0.017*
Cirrhosis
No 37 64.2 58.1 51.4 39.9
Yes 75 68.0 47.7 0.440 48.0 33.3 0.457
AFP (μg/l)b
≤ 400 55 61.3 53.4 49.1 39.7
> 400 57 71.9 48.7 0.699 49.1 31.6 0.714
Tumor size
≤ 5 cm 37 75.7 58.9 51.4 39.9
> 5 cm 75 62.3 46.8 0.398 48.0 33.3 0.938
Tumor number
Single 86 71.8 57.1 55.8 43.9
Multiple 26 50.0 30.8 <0.001* 26.9 7.7 <0.001*
Tumor capsule
Complete 20 75.0 52.2 50.0 44.4
Incomplete 92 65.0 50.5 0.507 48.9 33.7 0.611
Vascular invasion
No 86 67.2 55.0 53.5 41.6
Yes 26 65.4 37.1 0.011* 34.6 15.4 0.004*
Edmondson grade
I/II 64 76.3 56.0 64.1 44.8
III/IV 48 54.2 43.7 0.027* 29.2 22.9 0.002*
TNM stage
I/II 67 69.8 62.0 58.2 47.5
III/IV 45 62.2 34.0 <0.001* 35.6 17.8 0.001*
DDR2 level
Low 56 83.7 66.3 69.6 53.1
High 56 50.0 35.7 <0.001* 28.6 17.9 <0.001*
aHbsAg hepatitis B surface antigen, bAFP a-fetoprotein, *P < 0.05
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data indicates that the DDR2 expression level is an inde-
pendent prognosis factors of HCC patients.
Overexpression of DDR2 is associated with DDR2 activation
To explore whether DDR2 overexpression is associated
with DDR2 activation, we detected the phosphorylatedDDR2 (p-DDR2) expression in HCC cells, which was
previously shown to be associated with DDR2 activa-
tion in several studies. As expected, overexpression of
DDR2 evidently increased the level of p-DDR2 in
Hep3B cells (Fig. 2c). Furthermore, knockdown of
DDR2 expression markedly attenuated the phosphoryl-
ation of DDR2 in MHCC-97H cells (Fig. 2d). Our
Table 4 Multivariate analysis of factors contributing to overall survival and disease-free survival in HCC patients
Variable Overall survival rate Disease-free survival rate
HR (95 % CI)a P value HR (95 % CI)a P value
HBsAg statusb 3.021(1.335–6.836) 0.008* 2.556 (1.300–5.026) 0.007*
Tumor number 2.374 (1.117–5.045) 0.025* 2.758 (1.363–5.579) 0.005*
Vascular invasion 0.912 (0.451–1.847) 0.799 1.086 (0.553–2.136) 0.810
TNM stage 1.269 (0.579–2.784) 0.552 0.950 (0.463–1.953) 0.890
Edmondson grade 0.999 (0.574–1.739) 0.998 1.389 (0.854–2.260) 0.185
DDR2 level 2.169 (1.198–3.927) 0.011* 2.051 (1.228–3.425) 0.006*
aHR hazard ratio, bHbsAg hepatitis B surface antigen, CI confidence interval, *P < 0.05
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with DDR2 activation.
DDR2 promotes EMT and enhances invasion and
migration ability in HCC
We up-regulated DDR2 expression in Hep3B cells by
DDR2 expressing plasmid. Transwell assays were per-
formed to detect the effect of altering DDR2 expression
levels on HCC cell invasion and migration. In our study,
we found that up-regulation of DDR2 expression obviously
promoted HCC cell migration and invasion (P < 0.01,
respectively, Fig. 3a). Next, we down-regulated DDR2
expression by DDR2-shRNA vectors in MHCC-97H
cells. As expected, silencing DDR2 was found to inhibit
MHCC-97H cell migration and invasion by Transwell
assays (P < 0.05, respectively, Fig. 3b). Moreover, DDR2
overexpression-induced EMT was associated with reduced
E-cadherin expression and elevated Vimentin expression
in Hep3B cells (P < 0.01, respectively, Fig. 3c). Otherwise,
silencing DDR2-induced suppression of EMT in MHCC-
97H cells was associated with elevated E-cadherin expres-
sion and reduced Vimentin expression. Our data indicate
that DDR2 expression is associated with EMT phenotype
and tumor cell migration and invasion in HCC (P < 0.01,
respectively, Fig. 3d).
DDR2 facilitates EMT via activating ERK signaling and
stabilizing SNAIL1
To explore the underlying mechanism by which DDR2
regulates cell migration, invasion and EMT in HCC, we
detected the effect of DDR2 on several transcription fac-
tors considered to be inducers of EMT, such as SNAIL1,
TWIST1 and ZEB1. We found that up-regulation of
DDR2 in Hep3B cells increased the SNAIL1 protein
expression and knockdown of DDR2 in MHCC-97H
cells resulted in a decreased level of SNAIL1 protein.
However, overexpression or depletion of DDR2 did not
alter the expression of TWIST1 and ZEB1. (Fig. 4a-b).
Notably, overexpression or depletion of DDR2 did not
alter SNAIL1 mRNA expression (Fig. 4c-d). Considering
the fact that DDR2 controls the SNAIL1 expression post-
translationally, cycloheximide chase experiments wereperformed to detect the half-life of SNAIL1. As ex-
pected, DDR2 overexpression in Hep3B cells obviously
increased the half-life of SNAIL1 and DDR2 depletion
in MHCC-97H cells markedly decreased the half-life of
SNAIL1 (Fig. 4e-f ).
Next, expression of DDR2 and SNAIL1 was assessed
by immunohistochemistry in HCC and matched tumor-
adjacent tissues. Both DDR2 and SNAIL1 levels were
found to be evidently higher in HCC samples as com-
pared with those in corresponding adjacent no tumorous
samples (Fig. 5a-b). And there was indeed an evident
positive correlation between the expression of DDR2
and SNAIL1 (r = 0.605, P < 0.01, Spearman’s correlation
test) (Fig. 5c-d). To further figure out the role of DDR2
in the stabilization of SNAIL1 in HCC cells, we exam-
ined whether DDR2 directly interacted with SNAIL1
using co-immunoprecipitation assay. However, the co-
immunoprecipitation measurement revealed that DDR2
protein was not bound with SNAIL1 protein directly in
MHCC-97H cells (data not shown).
Since ERK activation was recently shown to be critical
for SNAIL1 stabilization and EMT induction, we investi-
gated the ERK activation and its correlation with DDR2,
SNAIL1 and EMT in HCC cells [29]. We found that
overexpression of DDR2 in Hep3B cells increased the
expression of p-ERK2, SNAIL1 and Vimentin and de-
creased the E-cadherin expression (Fig. 6a). DDR2 deple-
tion in MHCC-97H cells resulted in a down-regulation
of p-ERK2, SNAIL1 and Vimentin and an up-regulation
of E-cadherin (Fig. 6b). ERK2 depletion in MHCC-97H
cells attenuated the expression of SNAIL1, and Vimentin
and increased the E-cadherin expression. (Fig. 6b). SNAIL1
depletion in MHCC-97H cells decreased the Vimentin
expression and increased the E-cadherin expression
(Fig. 6b). To further confirm the role of ERK2 in DDR2-
induced SNAIL1 stabilization in HCC cells, we examined
whether ERK2 directly interacted with SNAIL1 using
co-immunoprecipitation assay. As expected, the co-
immunoprecipitation measurement revealed that ERK2
protein was bound with SNAIL1 protein directly in
MHCC-97H cells (Fig. 6c). Thus, these data strongly sug-
gest that DDR2 regulates SNAIL1 stability via stimulating
Fig. 3 DDR regulates HCC cell mobility and EMT phenotype. a Cell migration and invasion as measured by Transwell assays were promoted by
up-regulation of DDR2 in Hep3B cells as compared with control cells (n = 6, P < 0.01). b Cell migration and invasion as measured by Transwell assays
were inhibited by down-regulation of DDR2 in MHCC-97H cells as compared with control cells (n = 6, P < 0.01). c Immunoblotting analysis of
E-cadherin and Vimentin in Hep3B cells with DDR2 expressing plasmid transfection or control plasmid transfection (n = 6, P < 0.01). d Immunoblotting
analysis of E-cadherin and Vimentin in MHCC-97H cells with DDR2-shRNA transfection or control-shRNA transfection (n = 6, P < 0.01)
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factor in HCC cell migration, invasion and EMT.
DDR2 up-regulates MT1-MMP and MMP2 expression
through ERK2/ SNAIL1 signaling in HCC
It is well known that DDR2 can regulate metalloprotein-
ase activity in stellate cells [12]. And DDR2 expression
has been associated with increased MMPs expression
[13, 30]. To better understand the downstream mole-
cules involved in DDR2 signaling-induced HCC migra-
tion and invasion, we identified whether DDR2 affected
MT1-MMP and MMP2 expression in HCC cells. In our
study, we found that up-regulation of DDR2 expression
obviously increased MT1-MMP and MMP2 expression
in Hep3B cells (Fig. 6d). In contrary, knockdown of DDR2
expression markedly decreased the MT1-MMP andMMP2 expression in MHCC-97H cells (Fig. 6e). Further-
more, we found that DDR2 up-regulated MT1-MMP and
MMP2 expression through ERK2/SNAIL1 signaling in
HCC cells (Fig. 6e).
Collagen I induces DDR2/ERK2/SNAIL1 signaling
activation in HCC
Considering the fact that DDR2 belongs to RTK family
and type I collagen is the DDR2 ligand, we examined the
effect of collagen I on the DDR2 phosphorylation. In our
study, exposure of HCC cells to collagen I resulted in
tyrosine phosphorylation and activation of DDR2 (Fig. 6f).
Recently, it was shown that collagen I can activate DDR2/
ERK2/SNAIL1 signaling axis in breast cancer. To better
understand the underlying mechanism of DDR2 in HCC,
we further determined whether collagen I affected DDR2/
Fig. 4 The effect of DDR2 on the expression of SNAIL1, TWIST1 and ZEB1 in HCC cells. a Immunoblotting analysis of SNAIL1, TWIST1 and ZEB1
in Hep3B cells with DDR2 expressing plasmid transfection or control plasmid transfection (n = 3, P < 0.01). b Immunoblotting analysis of SNAIL1,
TWIST1 and ZEB1 in MHCC-97H cells with DDR2-shRNA transfection or control-shRNA transfection (n = 3, P < 0.01). c qRT-PCR analysis of SNAIL1
in Hep3B cells with DDR2 expressing plasmid transfection or control plasmid transfection (n = 3, *P < 0.01). d qRT-PCR analysis of SNAIL1 in MHCC-97H
cells with DDR2-shRNA transfection or control-shRNA transfection (n = 3, *P < 0.01). e Cycloheximide (CHX) treated samples analysis following
DDR2 expressing plasmid transfection or control plasmid transfection in Hep3B cells (n = 3, *P < 0.01). f Cycloheximide (CHX) treated samples
analysis following DDR2-shRNA transfection or control-shRNA transfection in MHCC-97H cells (n = 3, *P < 0.01)
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study, we found that collagen I significantly activates
DDR2/ERK2/SNAIL1 signaling axis in HCC (Fig. 6f).
Discussion
DDR2, a receptor tyrosine kinase, is considered to be in-
volved in the progression of many cancer types [16, 23].
Increasing evidences have demonstrated that up-regulation
of DDR2 is commonly observed in multiply tumor
types including breast and prostate cancer [18, 15].
Moreover, several researches revealed that activated DDR2
could up-regulate the expression level of MMP-1, MMP-2
and MMP-13 [12, 13, 30].
Here we revealed that DDR2 expression in HCC cell
lines was obviously higher than that in immortalized
non-tumourigenic hepatocyte cell line L02. Our findings
also showed that DDR2 expression was significantly higher
in HCC tissues compared with matched normal tumor-
adjacent tissues. Furthermore, high DDR2 level was
evidently correlated with tumor number, vascular invasion,
Edmondson-Steiner grade and TNM stage in HCC.
Importantly, our results indicates that overexpressionof DDR2 was obviously correlated with shorter OS
and DFS, which is an assumed molecular marker for
poor prognosis in HCC. Additionally, Cox repression
analysis confirmed that DDR2 is a novel independent
factor for HCC. Taken together, our results demon-
strated that DDR2 overexpression may promote tumor
progression and is a critical factor for prognosis deter-
mination in HCC patients.
In this study, we detected the phosphorylated DDR2
expression level (p-DDR2), which was previously shown
to be associated with DDR2 activation. Our data indicate
that DDR2 overexpression is related to the increase in
activated p-DDR2. In our study, we also investigated the
role of DDR2 in HCC cells. We found that up-regulation
of DDR2 obviously promoted cell migration and invasion
in Hep3B cells. In contrast, DDR2 depletion significantly
inhibited cell migration and invasion in MHCC-97H cells.
Our data suggest that DDR2 indeed facilitates the migra-
tion and invasion of HCC cell. EMT, a dynamic biological
process, is crucial in the development of invasiveness and
metastatic potential of many cancers including HCC [29].
The enhanced EMT process in tumor cells has been
Fig. 5 Immunohistochemical staining of DDR2 and SNAIL1 in HCC tissues. a The IHC scores of DDR2 in HCC tissues was notably higher than that
in the corresponding adjacent no tumorous tissues (NT) (n = 112, P < 0.01). b The IHC scores of SNAIL1 in HCC tissues was notably higher than
that in the corresponding adjacent no tumorous tissues (NT) (n = 112, P < 0.01). c In cases of high DDR2 protein expression, there was strong
SNAIL1 protein expression in the same tissue section. Similarly, in the case of low DDR2 protein expression, there was no detectable SNAIL1
protein expression in the same tissue section (scale bar: 100 μm). d Linear regression analysis showed a significant positive correlation between
ACK1 and p-ACK1 protein expression (P < 0.01)
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and is associated with negative prognosis in patients
with HCC [31]. Thus, we detected the expression of
epithelial biomarker, E-cadherin, and mesenchymal
biomarker, Vimentin with altering DDR2 expression in
HCC cells. Notably, DDR2 overexpression markedly
facilitates EMT and is associated with reduced E-cadherin
level and elevated Vimentin level. Meanwhile, DDR2
depletion significantly inhibits EMT and is associated
with elevated E-cadherin level and reduced Vimentin
level. Our results revealed that DDR2 may promote HCC
cell migration and invasion via inducing EMT.
Many signals generated within the cancer microenvir-
onment activate transcription factors considered to be
promoters of EMT, such as SNAIL1, TWIST1 and ZEB1
[23, 32]. Here we detected the effect of DDR2 on these
transcription factors in HCC cells. Overexpression or
depletion of DDR2 affected the protein expression of
SNAIL1, whereas the level of TWIST1 and ZEB1 was
unchanged. Notably, overexpression or depletion of DDR2
did not alter SNAIL1 mRNA expression. Furthermore,
there was indeed an evident positive correlation between
the expression of DDR2 and SNAIL1 in HCC tissues.
Interestingly, we demonstrated that DDR2 protein wasnot bound with SNAIL1 protein directly in MHCC-97H
cells. Our results revealed that SNAIL1 stabilization by
DDR2 was unlikely to be the result of direct interaction
by DDR2.
The ERK signaling is a ubiquitous signal transduction
pathway that regulates important cellular processes, such
as proliferation, migration and invasion [29, 33]. Increas-
ing evidences have demonstrated that the activation of
ERK is believed to contribute to tumorigenesis in many
cancer types including HCC [29, 24]. Notably, ERK acti-
vation was recently shown to be critical for SNAIL1
stabilization and EMT induction [23]. Here we investi-
gated the ERK activation and its correlation with DDR2
and SNAIL1 in HCC cells. Overexpression or depletion
of DDR2 affected p-ERK2 expression, whereas the level
of p-ERK1 was unchanged. Moreover, ERK2 depletion
attenuated the SNAIL1 level in HCC cells. Importantly,
ERK2 protein was bound with SNAIL1 protein directly
in HCC cells. Our data strongly suggest that DDR2
regulates SNAIL1 stability via stimulating ERK2 activity.
MMPs activity has been related with cancer cell mi-
gration and invasion [28]. As two members of MMPs,
MT1-MMP and MMP2 are critical factors in the mi-
gration and invasion of HCC [34, 28]. Considering the
Fig. 6 DDR2 induces EMT and up-regulates the expression of MTI-MMP and MMP2 through ERK2/SNAIL1 signaling in HCC cells. a Hep3B cells
that had been transfected with DDR2 expressing plasmid or control plasmid, respectively, were subjected to western blotting for ERK1/2, p-ERK1/2, SNAIL1,
Vimentin and E-cadherin. b MHCC-97H cells that had been transfected with control-shRNA, DDR2-shRNA, control-siRNA, ERK2-siRNA, control-siRNA or
SNAIL1-siRNA, respectively, were subjected to western blotting for DDR2, ERK1/2, p-ERK1/2, SNAIL1, Vimentin and E-cadherin). c Co-immunoprecipitation
assays showed that ERK2 was bound with SNAIL1 directly. d Hep3B cells that had been transfected with DDR2 expressing plasmid or control
plasmid, respectively, were subjected to western blotting for ERK1/2, p-ERK1/2, SNAIL1, MTI-MMP and MMP2. e MHCC-97H cells that had been
transfected with control-shRNA, DDR2-shRNA, control-siRNA, ERK2-siRNA, control-siRNA or SNAIL1-siRNA, respectively, were subjected to western
blotting for DDR2, ERK1/2, p-ERK1/2, SNAIL1, MTI-MMP and MMP2. f HCC cells that had been transfected with indicated plasmids were added to plates
coated with collagen I (2 mg/ml, BD Biosciences) for 8 h and western blotting were performed
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the expression of MMPs, we identified whether DDR2
affected MT1-MMP and MMP2 expression in HCC
cells [12, 13]. We found that up-regulation of DDR2
expression obviously increased MT1-MMP and MMP2
expression and DDR2 depletion markedly decreased
the MT1-MMP and MMP2 expression. Furthermore,
DDR2 up-regulates MT1-MMP and MMP2 expression
through ERK2/SNAIL1 signaling in HCC cells. These
data suggest that DDR2-induced ERK2/SNAIL1 signal-
ing activation may be responsible for the progression
of EMT and up-regulation of MT1-MMP and MMP2
expression, which in turn facilitates migration and in-
vasion of HCC.
DDR2 belongs to RTK family and type I collagen is
the DDR2 ligand. Recently, it was shown that the type I
collagen can activate DDR2/ERK2/SNAIL1 signaling axis
in breast cancer. In our study, we found that collagen I
can activate DDR2/ERK2/SNAIL1 signaling axis in HCC
cells. Our results are consistent with previous findingson breast cancer, suggesting the type I collagen can cause
DDR2 phosphorylation and induce DDR2/ERK2/SNAIL1
signaling axis hyperactivation.
In summary, we found that DDR2 expression level is
up-regulated in HCC as compared with non-cancerous
liver samples and that overexpression of DDR2 is correlated
with clinicopathological characteristics of poor prognosis
in HCC. Additionally, we found that DDR2 level is an
independent factor for predicting the overall survival
and disease-free survival of patients with HCC. Not-
ably, DDR2 can facilitate cell invasion, migration and
epithelial–mesenchymal transition via activating ERK
signaling and stabilizing SNAIL1 and up-regulate MT1-
MMP and MMP2 expression through ERK2/SNAIL1
signaling in HCC.
Conclusions
Our study provides a better understanding on both the
molecular mechanism and functional role of DDR2 in
human HCC. Our current work revealed that DDR2 has
Xie et al. Journal of Experimental & Clinical Cancer Research  (2015) 34:101 Page 12 of 13an oncogenic role in hepatocarcinogenesis by facilitating
cancer cell invasion, migration and EMT via activating
ERK2 and stabilizing SNAIL1. Notably, DDR2 can up-
regulate MT1-MMP and MMP2 expression through
ERK2/SNAIL1 signaling in HCC. Our study identified
that DDR2 is a novel regulator of EMT via DDR2-
induced ERK2/SNAIL1 signaling activation, indicating
its potential therapeutic value for reducing HCC invasion
and metastasis.
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